Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

NCT01131065 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B
Liver Transplantation

Interventions

DRUG: Hepatitis B immune globulin

Sponsor

Instituto Grifols, S.A.